CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

tPA in Stroke: 'The Facts Are Clear'

Published: Fri, 20 Apr 2018 10:31:41 EDT
Thrombolytic treatment for stroke remains controversial among specialties. Here, a neurologist argues for its use.
Medscape Neurology

Depression in Young Women: Often There, Often Overlooked

Published: Fri, 20 Apr 2018 10:15:17 EDT
Dr. Arefa Cassoobhoy highlights a gap in treating depression in young women.
Medscape Internal Medicine

Marijuana and the Developing Brain: Current State of Evidence

Published: Fri, 20 Apr 2018 10:06:34 EDT
What do we know about the effect of marijuana on the adolescent brain?
Medscape Pediatrics
Displaying results 16-18 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Grid Therapeutics raises $5M for complement-activating I-O drug

Published: Wed, 18 Apr 2018 13:00:10 +0000
Grid Therapeutics is planning to start trials of its lead cancer immunotherapy GT103 next year after raising $5 million in second-round financing.

Oncolytics Biotech’s CMO departs on cusp of phase 3 trial

Published: Wed, 18 Apr 2018 12:37:45 +0000
Oncolytics Biotech has lost its CMO shortly before it is due to start a pivotal metastatic breast cancer trial. Andres Gutierrez, M.D., Ph.D., is leaving to pursue other opportunities after spending 18 months as CMO of the Canadian microcap.

Johnson & Johnson scraps phase 3 antibiotic program acquired in $30B Actelion takeover

Published: Tue, 17 Apr 2018 12:54:18 +0000
Johnson & Johnson has halted development of cadazolid in clostridium difficile-associated diarrhea. The antibiotic was one of two experimental assets J&J acquired in its $30 billion takeover of Actelion last year.
Displaying results 16-18 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top